首页|期刊导航|iLIVER|Efficacy and safety of PD-1 inhibitors for advanced intrahepatic cholangiocarcinoma with or without MAFLD

Efficacy and safety of PD-1 inhibitors for advanced intrahepatic cholangiocarcinoma with or without MAFLD

Teng Long Zhenyun Yang Weijie Wu Minshan Chen Dandan Hu

iLIVER2025，Vol.4Issue(2)：P.81-89,9.

iLIVER2025，Vol.4Issue(2)：P.81-89,9.DOI:10.1016/j.iliver.2025.100169

Efficacy and safety of PD-1 inhibitors for advanced intrahepatic cholangiocarcinoma with or without MAFLD

Teng Long ¹Zhenyun Yang ¹Weijie Wu ¹Minshan Chen ¹Dandan Hu¹

作者信息

1. Department of Liver Surgery,Sun Yat-sen University Cancer Center,Guangzhou 510000,Guangdong,China Collaborative Innovation Center for Cancer Medicine,State Key Laboratory of Oncology in South China,Sun Yat-Sen University Cancer Center,Guangzhou 510000,Guangdong,China Guangdong Provincial Clinical Research Center for Cancer,Sun Yat-Sen University Cancer Center,Guangzhou 510000,Guangdong,China
折叠

摘要

关键词

Intrahepatic cholangiocarcinoma/Programmed cell death protein-1 inhibitor/Metabolic dysfunction-associated fatty liver disease/Tumor response/Adverse events

分类

医药卫生

引用本文复制引用

Teng Long,Zhenyun Yang,Weijie Wu,Minshan Chen,Dandan Hu..Efficacy and safety of PD-1 inhibitors for advanced intrahepatic cholangiocarcinoma with or without MAFLD[J].iLIVER,2025,4(2):P.81-89,9.

基金项目

supported by grants from the National Natural Science Foundation of China(No:82472801,82103566) （No:82472801,82103566）

Basic and Applied Basic Research of Guangzhou Science and Technology Plan Project(No:2023A04J2123). （No:2023A04J2123）

iLIVER

ISSN：2772-9478

访问量0

下载量0

段落导航